Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme

Cloretazine (VNP40101M) is a newly synthesized alkylating agent belonging to a novel class of alkylating agents called 1,2-bis(sulfonyl)hydrazines. Agents that belong to this class do not produce vinylating and chloroethylating species, and hence this class of alkylating agents is thought to have mi...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Badruddoja, Michael A., Penne, Kara, Desjardins, Annick, Reardon, David A., Rich, Jeremy N., Quinn, Jennifer A., Sathornsumetee, Sith, Friedman, Allan H., Bigner, Darell D., Herndon, James E., Cahill, Ann, Friedman, Henry S., Vredenburgh, James J.
Формат: Artigo
Язык:Inglês
Опубликовано: Duke University Press 2007
Предметы:
Clinical Investigations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1828104/
https://ncbi.nlm.nih.gov/pubmed/17108065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2006-022
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы